Nemus Bioscience Inc.

(NMUS)

By |

Profile

Nemus Bioscience Inc is a life science biopharmaceutical company. It is engaged in the discovery, development, and the commercialization of cannabinoid-based therapeutics. The company is focused on the development of early-stage cannabinoid product candidates which includes NB1111 for the treatment of glaucoma, NB1222 which is used for chemotherapy Induced nausea and vomiting, NB3111 for the treatment of methicillin-resistant staphylococcus aureus, NB2111 for treating chemotherapy Induced peripheral neuropathy and NB2222 used in the treatment of uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy.

Contact Information

Website: www.nemusbioscience.com
Main Phone: +1 949 396-0330
Address: 600 Anton Boulevard
Address 2: Suite 1100
State: CA
City / Town: Costa Mesa
Country: USA
Postal Code: 92626

Issuer Information

Exchange: OTCQB
CEO: Brian S. Murphy
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.33 $ -0.00565 (-1.67%)
Last Price 0.33 Change $ -0.00565 Change % -1.67 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.33 High 0.37 Low 0.31 Prev Close 0.34
Last Trade Volume 226,785 52 Wk Hi 0.60 52 Wk Low 0.05
Market Cap 44.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 133,870,080.00 EPS (TTM) -0.12 PE Ratio N/A Exchange OTCQB
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 3
Number of Buys 0 3
Number of Sells 0 0
Net Activity 0 2500000
Last 10 Buys Shares
Gerald McLaughlin 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2 2 2 2
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 2 2 2 2
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/04/16 04/04/16 04/04/16 04/04/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1